«Arrivato, ma dove?». La riscoperta dell'esilio in Ursula Krechel

The article analyzes two recent successful novels by Ursula Krechel that return to the recent German past: Shanghai Far from Where, 2008 (extracts published in: “The Hudson Review”, spring 2015, vol. 68 , I, pp. 39-60) and Regional Court, 2012, which won an important German book prize. In both postmodern texts the author investigates the exile of German speaking Jews in the Chinese metropolis (Shanghai) and the difficulties of returning Jews immediately after the war to Germany where they find incomprehension, rejection and all sorts of bureaucratic obstacles. For those who have been in exile there is no real return even after the end of the war (Regional Court)

Scrivere io, scrivere (l'altro): immagini della memoria. Studi su Christa Wolf

Questo volume di studi si propone di riprendere una tradizione della germanistica italiana che negli anni Ottanta e Novanta del Novecento ha dedicato ampie ricerche alla letteratura e alla cultura della DDR; allo stesso tempo desidera porre le basi per nuove chiavi di lettura dell’opera della scrittrice tedesco-orientale Christa Wolf, ponendola in relazione con la letteratura e la cultura contemporanea, con la scrittura dell’altro e con la scrittura “altra”, intesa come scrittura alternativa, sotterranea, poco esplicita, che rivela identità “latenti”, dimenticate, in via di definizione

Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset.

Early-onset colorectal cancer has been on the rise in Western populations. Here, we compare patient characteristics between those with early- (<50 years) vs. late-onset (≥50 years) disease in a large multinational cohort of colorectal cancer patients (n = 2193). We calculated descriptive statistics and assessed associations of clinicodemographic factors with age of onset using mutually-adjusted logistic regression models. Patients were on average 60 years old, with BMI of 29 kg/m2, 52% colon cancers, 21% early-onset, and presented with stage II or III (60%) disease. Early-onset patients presented with more advanced disease (stages III-IV: 63% vs. 51%, respectively), and received more neo and adjuvant treatment compared to late-onset patients, after controlling for stage (odds ratio (OR) (95% confidence interval (CI)) = 2.30 (1.82-3.83) and 2.00 (1.43-2.81), respectively). Early-onset rectal cancer patients across all stages more commonly received neoadjuvant treatment, even when not indicated as the standard of care, e.g., during stage I disease. The odds of early-onset disease were higher among never smokers and lower among overweight patients (1.55 (1.21-1.98) and 0.56 (0.41-0.76), respectively). Patients with early-onset colorectal cancer were more likely to be diagnosed with advanced stage disease, to have received systemic treatments regardless of stage at diagnosis, and were less likely to be ever smokers or overweight